In 2020, 39 percent of surveyed U.S. biopharma executives stated that company valuations increased by 10 percent to 20 percent; while 23 percent believed that valuations exceeded 20 percent. This statistic illustrates the changes in valuations of biopharmaceutical companies worldwide according to U.S. biopharma executives.
Changes in valuations of biopharmaceutical companies according to U.S. executives in 2020, by extent
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
KPMG. (April 26, 2021). Changes in valuations of biopharmaceutical companies according to U.S. executives in 2020, by extent [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1239370/extent-of-valuation-changes-of-biopharma-companies/
KPMG. "Changes in valuations of biopharmaceutical companies according to U.S. executives in 2020, by extent." Chart. April 26, 2021. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1239370/extent-of-valuation-changes-of-biopharma-companies/
KPMG. (2021). Changes in valuations of biopharmaceutical companies according to U.S. executives in 2020, by extent. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1239370/extent-of-valuation-changes-of-biopharma-companies/
KPMG. "Changes in Valuations of Biopharmaceutical Companies According to U.S. Executives in 2020, by Extent." Statista, Statista Inc., 26 Apr 2021, https://www.statista.com/statistics/1239370/extent-of-valuation-changes-of-biopharma-companies/
KPMG, Changes in valuations of biopharmaceutical companies according to U.S. executives in 2020, by extent Statista, https://www.statista.com/statistics/1239370/extent-of-valuation-changes-of-biopharma-companies/ (last visited July 22, 2024)
Changes in valuations of biopharmaceutical companies according to U.S. executives in 2020, by extent [Graph], KPMG, April 26, 2021. [Online]. Available: https://www.statista.com/statistics/1239370/extent-of-valuation-changes-of-biopharma-companies/
